CRNX (STOCKS)
Crinetics Pharmaceuticals, Inc.
$38.660000
-0.780000 (-1.98%)
Prev close: $39.440000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Scott R. Struthers
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,044.77M
- Employees
- 437
- P/E (TTM)
- -7.98
- P/B (TTM)
- 3.80
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $7.70M |
| Benefits Costs and Expenses | $472.83M |
| Cost Of Revenue | $1.08M |
| Costs And Expenses | $524.47M |
| Gross Profit | $6.62M |
| Nonoperating Income/Loss | $51.63M |
| Operating Expenses | $523.39M |
| Selling, General, and Administrative Expenses | $191.33M |
| Depreciation and Amortization | $3.89M |
| Research and Development | $332.06M |
| Operating Income/Loss | -$516.77M |
| Income/Loss Before Equity Method Investments | -$465.14M |
| Income/Loss From Continuing Operations After Tax | -$465.32M |
| Income/Loss From Continuing Operations Before Tax | -$465.14M |
| Income/Loss From Equity Method Investments | $0.00 |
| Income Tax Expense/Benefit | $180.00K |
| Income Tax Expense/Benefit, Current | $180.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$465.32M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$465.32M |
| Net Income/Loss Available To Common Stockholders, Basic | -$465.32M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.95 |
| Diluted Earnings Per Share | -$4.95 |
| Basic Average Shares | 94,057,000 |
| Diluted Average Shares | 94,057,000 |
| Assets | $1.13B |
| Current Assets | $1.05B |
| Cash | $1.00B |
| Inventory | $2.02M |
| Other Current Assets | $46.32M |
| Noncurrent Assets | $77.92M |
| Fixed Assets | $14.30M |
| Other Non-current Assets | $63.62M |
| Liabilities | $134.17M |
| Current Liabilities | $85.07M |
| Accounts Payable | $22.61M |
| Other Current Liabilities | $62.46M |
| Noncurrent Liabilities | $49.10M |
| Equity | $992.08M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $992.08M |
| Liabilities And Equity | $1.13B |
| Net Cash Flow From Operating Activities | -$377.92M |
| Net Cash Flow From Operating Activities, Continuing | -$377.92M |
| Net Cash Flow From Investing Activities | $173.91M |
| Net Cash Flow From Investing Activities, Continuing | $173.91M |
| Net Cash Flow From Financing Activities | $40.61M |
| Net Cash Flow From Financing Activities, Continuing | $40.61M |
| Net Cash Flow | -$163.40M |
| Net Cash Flow, Continuing | -$163.40M |
| Comprehensive Income/Loss | -$464.42M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$464.42M |
| Other Comprehensive Income/Loss | $902.00K |
| Other Comprehensive Income/Loss Attributable To Parent | $902.00K |